NONINVASIVE TEST FOR MANAGEMENT OF NONULCER DYSPEPSIA
Nonulcer dyspepsia is a highly prevalent medical condition affecting up to 30 percent of the Western population, accounting for 2-5 percent of all visits to primary care physicians and leads
to over one billion dollars worth of upper endoscopy procedures per year. In an
attempt to lower this tremendous burden on the health care system the general
practice currently is to attempt to avoid endoscopy in the majority of
patients, which are low risk, by an initial empiric trial of medication.
Endoscopy can then be performed on those that fail initial therapy.
Unfortunately, empiric treatment is only effective in about 40-50 percent of
cases since it is difficult to determine in advance the most effective
treatment. Consequently the high cost of endoscopy continues to be a problem.
The overall goal of this project is to develop an inexpensive, non-invasive
test for the objective and quantitative categorization of nonulcer dyspepsia
patients with the purpose of providing the most effective initial treatment.
The effectiveness of objective patient categorization will be tested with
respect to ability to predict which patients will be responders to acid
suppression therapy and which will be responsive to prokinetic treatment.
Small Business Information at Submission:
WESTERN RESEARCH COMPANY, INC.
WESTERN RESEARCH COMPANY, INC. 2127 E SPEEDWAY, STE 209 TUCSON, AZ 85719
Number of Employees: